Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans.
Nasal spray vaccine prevents infection from highly pathogenic H5N1 virus
